Effect of an antimitotic agent (cyclophosphamide) on post-heparin plasma lipoprotein lipase activity in rabbit

Palliative care integration and end-of-life care intensity for patients with NSCLC.

Lung cancer (Amsterdam, Netherlands)·2024

Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study).

ESMO open·2024

Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors.

Lung cancer (Amsterdam, Netherlands)·2023

Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort.

Breast cancer research and treatment·2022

De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.

European journal of cancer (Oxford, England : 1990)·2021

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database.

ESMO open·2021

KIF4A stabilizes TDP43 to promote DNA damage repair and temozolomide resistance in glioblastoma.

Biochemical pharmacology·2026

GLP-1 receptor agonists and podocyte senescence in diabetic kidney disease: structural pharmacology, mechanistic evidence, and multi-receptor agonism.

Biochemical pharmacology·2026

Combination pharmacotherapy for MASH: Potential synergistic approaches.

Biochemical pharmacology·2026

Metabolic reprogramming of decidual macrophages impairs maternal-fetal interface homeostasis and contributes to recurrent spontaneous abortion.

Biochemical pharmacology·2026

Non-invasive evaluation of early liver fibrosis process by targeting αvβ6 integrin PET imaging.

Biochemical pharmacology·2026

Trillin alleviates rheumatoid arthritis by inhibiting TXNIP-mediated mitochondrial damage and NLRP3-dependent pyroptosis.

Biochemical pharmacology·2026

Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.

Cancer discovery·2026

Clinical and scintigraphic improvement of mandibular involvement associated with chronic nonbacterial osteitis following an interleukin-23 inhibitor: a case-based literature review.

Immunological medicine·2026

Navigating clozapine discontinuation in clinical practice: An updated framework.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026

Early progression after immune checkpoint inhibitor therapy in recurrent or metastatic head and neck squamous cell carcinoma: association with disease distribution in a single-center retrospective study.

Japanese journal of clinical oncology·2026

Evaluation of the protective effects of green tea for ischemia-reperfusion injury in rat ovary tissue: an experimental study.

Acta cirurgica brasileira·2026

Early intervention with clozapine: Is there a neurobiological critical period for treatment-resistant schizophrenia?

Journal of psychopharmacology (Oxford, England)·2026

Related Experiment Videos

Effect of an antimitotic agent (cyclophosphamide) on post-heparin plasma lipoprotein lipase activity in rabbit

Related Concept Videos

Palliative care integration and end-of-life care intensity for patients with NSCLC.

Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study).

Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors.

Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort.

De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database.

KIF4A stabilizes TDP43 to promote DNA damage repair and temozolomide resistance in glioblastoma.

GLP-1 receptor agonists and podocyte senescence in diabetic kidney disease: structural pharmacology, mechanistic evidence, and multi-receptor agonism.

Combination pharmacotherapy for MASH: Potential synergistic approaches.

Metabolic reprogramming of decidual macrophages impairs maternal-fetal interface homeostasis and contributes to recurrent spontaneous abortion.

Non-invasive evaluation of early liver fibrosis process by targeting αvβ6 integrin PET imaging.

Trillin alleviates rheumatoid arthritis by inhibiting TXNIP-mediated mitochondrial damage and NLRP3-dependent pyroptosis.

Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.

Clinical and scintigraphic improvement of mandibular involvement associated with chronic nonbacterial osteitis following an interleukin-23 inhibitor: a case-based literature review.

Navigating clozapine discontinuation in clinical practice: An updated framework.

Early progression after immune checkpoint inhibitor therapy in recurrent or metastatic head and neck squamous cell carcinoma: association with disease distribution in a single-center retrospective study.

Evaluation of the protective effects of green tea for ischemia-reperfusion injury in rat ovary tissue: an experimental study.

Early intervention with clozapine: Is there a neurobiological critical period for treatment-resistant schizophrenia?

Related Experiment Videos

Effect of an antimitotic agent (cyclophosphamide) on post-heparin plasma lipoprotein lipase activity in rabbit

Related Concept Videos

Related Articles